New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness.
In the last few years, genetic and functional studies have provided important insight on the pathophysiology of excessive erythrocytosis (EE), the main sign of Chronic Mountain Sickness (CMS). The recent finding of the association of the CMS phenotype with a single-nucleotide polymorphism (SNP) in the Sentrin-specific Protease 1 (SENP1) gene, and its differential expression pattern in Andean highlanders with and without CMS, has triggered large interest in high-altitude studies because of the potential role of its gene product in the control of erythropoiesis. The SENP1 gene encodes for a protease that regulates the function of hypoxia-relevant transcription factors such as Hypoxia-Inducible Factor (HIF) and GATA, and thus might have an erythropoietic regulatory role in CMS through the modulation of the expression of erythropoietin (Epo) or Epo receptors. The different physiological patterns in the Epo-EpoR system found among Andeans, even among highlanders with CMS, together with their different degrees of erythropoietic response, might indicate specific underlying genetic backgrounds, which in turn might reflect different levels of adaptation to lifelong high-altitude hypoxia. This minireview discusses recent genetic findings potentially underlying EE and CMS, and their possible physiological mechanisms in Andean highlanders.
Laboratorio de Fisiología Comparada, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú francisco.villafuerte@upch.pe.
Francisco C
FC
Villafuerte
D000531:Altitude; D000532:Altitude Sickness / Q000097:blood* / Q000150:complications / Q000235:genetics* / Q000503:physiopathology; D002908:Chronic Disease; D006801:Humans; D011086:Polycythemia / Q000097:blood* / Q000150:complications / Q000235:genetics* / Q000503:physiopathology; D013020:South America
Andes; Chronic Mountain Sickness; chronic hypoxia; excessive erythrocytosis; high altitude